These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36017487)

  • 1. Prevalence of Serous Macular Detachment in Recurrent Macular Edema Secondary to Retinal Vein Occlusion.
    Şekeroğlu MA; Taşkale FB; Doğuizi S; Yılmazbaş P
    Turk J Ophthalmol; 2022 Aug; 52(4):276-280. PubMed ID: 36017487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ranibizumab versus Dexamethasone Implant in Macular Edema Secondary to Branch Retinal Vein Occlusion: Two-year Outcomes.
    Ozkaya A; Tarakcioglu HN; Tanir I
    Optom Vis Sci; 2018 Dec; 95(12):1149-1154. PubMed ID: 30451802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolution of serous macular detachment after intravitreal triamcinolone acetonide treatment of patients with branch retinal vein occlusion.
    Karacorlu M; Ozdemir H; Karacorlu SA
    Retina; 2005; 25(7):856-60. PubMed ID: 16205564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of vitreomacular adhesion in eyes with macular oedema secondary to retinal vein occlusion selected for intravitreal injections.
    Maggio E; Maraone G; Mete M; Vingolo EM; Grenga PL; Guerriero M; Pertile G
    Acta Ophthalmol; 2021 Nov; 99(7):e1154-e1161. PubMed ID: 33421346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
    Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
    Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ranibizumab for serous macular detachment in branch retinal vein occlusions.
    Gallego-Pinazo R; Dolz-Marco R; Pardo-López D; Martínez-Castillo S; Lleó-Pérez A; Arévalo JF; Díaz-Llopis M
    Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):9-14. PubMed ID: 22527327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion in a Chinese Population.
    Gu X; Yu X; Song S; Dai H
    Ophthalmic Res; 2017; 58(1):8-14. PubMed ID: 28334720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.
    Korobelnik JF; Kodjikian L; Delcourt C; Gualino V; Leaback R; Pinchinat S; Velard ME
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2307-2318. PubMed ID: 27286894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of intravitreal dexamethasone implant for the treatment of ranibizumab-resistant macular edema secondary to retinal vein occlusion.
    Manousaridis K; Peter S; Mennel S
    Int Ophthalmol; 2017 Feb; 37(1):47-53. PubMed ID: 27043320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy of intravitreal triamcinolone acetonide for cystoid macular edema with versus without serous retinal detachment in branch retinal vein occlusion: influence on macular sensitivity and morphology.
    Noma H; Funatsu H; Mimura T; Shimada K
    BMC Ophthalmol; 2012 Aug; 12():39. PubMed ID: 22876931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal triamcinolone acetonide for treatment of serous macular detachment in central retinal vein occlusion.
    Karacorlu M; Karacorlu SA; Ozdemir H; Senturk F
    Retina; 2007 Oct; 27(8):1026-30. PubMed ID: 18040239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Serum Inflammation-Based Factors in Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion and Its Subtypes.
    Rao J; Wu N; Qu X; Hu Y; Wu Y; Cheng Y; Yan L; Huang H; Li S; Shi L; Wu X
    Ophthalmic Res; 2021; 64(2):237-245. PubMed ID: 32506058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA.
    Nghiem-Buffet S; Baillif S; Regnier S; Skelly A; Yu N; Sodi A
    Eye (Lond); 2017 Apr; 31(4):551-559. PubMed ID: 27911446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RANIBIZUMAB FOR RETINAL VEIN OCCLUSION: Predictive Factors and Long-Term Outcomes in Real-Life Data.
    Chatziralli I; Theodossiadis G; Chatzirallis A; Parikakis E; Mitropoulos P; Theodossiadis P
    Retina; 2018 Mar; 38(3):559-568. PubMed ID: 28248827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual function and serous retinal detachment in patients with branch retinal vein occlusion and macular edema: a case series.
    Noma H; Funatsu H; Mimura T; Shimada K
    BMC Ophthalmol; 2011 Sep; 11():29. PubMed ID: 21943190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EVALUATION OF MULTIPLE DEXAMETHASONE INTRAVITREAL IMPLANTS IN PATIENTS WITH MACULAR EDEMA ASSOCIATED WITH RETINAL VEIN OCCLUSION.
    Bakri SJ; Omar AF; Iezzi R; Kapoor KG
    Retina; 2016 Mar; 36(3):552-7. PubMed ID: 26418442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive impact of optical coherence tomography biomarkers in anti-vascular endothelial growth factor resistant macular edema treated with dexamethasone implant.
    Horozoglu F; Sener H; Polat OA; Temizyurek O; Evereklioglu C
    Photodiagnosis Photodyn Ther; 2023 Jun; 42():103167. PubMed ID: 36261095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low frequency ranibizumab versus dexamethasone implant for macular oedema secondary to branch retinal vein occlusion.
    Yuksel B; Karti O; Celik O; Kerci SG; Kusbeci T
    Clin Exp Optom; 2018 Jan; 101(1):116-122. PubMed ID: 28922697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two or more dexamethasone intravitreal implants as monotherapy or in combination therapy for macular edema in retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Singer MA; Capone A; Dugel PU; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Apr; 15():33. PubMed ID: 25885285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.